A nebulizer includes a nebulizer top detachably coupled to a nebulizer bottom with a nozzle assembly that fits between the nebulizer top and nebulizer bottom. The components of the nebulizer are formed so that each be easily replaced by a counterpart component of similar design but with a different property. The nozzle assembly is configured to be replaced with a second nozzle assembly that has a different aperture size that produces a different size of aerosol droplet. Additionally, a diffuser attached to the nebulizer top or nebulizer bottom can be replaced by a second nebulizer top or nebulizer bottom with a second diffuser in a different position that produces a different size of aerosol droplet. A sensor module attached to the nebulizer measures properties associated with the performance of the nebulizer.
A nebulizer includes a nebulizer top detachably coupled to a nebulizer bottom with a nozzle assembly that fits between the nebulizer top and nebulizer bottom. The components of the nebulizer are formed so that each be easily replaced by a counterpart component of similar design but with a different property. The nozzle assembly is configured to be replaced with a second nozzle assembly that has a different aperture size that produces a different size of aerosol droplet. Additionally, a diffuser attached to the nebulizer top or nebulizer bottom can be replaced by a second nebulizer top or nebulizer bottom with a second diffuser in a different position that produces a different size of aerosol droplet. A sensor module attached to the nebulizer measures properties associated with the performance of the nebulizer.
A system evaluates a patient for a physiological abnormality. A urinary catheter is insertabfe within a patient's bladder and has a first pressure sensor for measuring bladder pressure and a second pressure sensor for measuring mid-urethra! pressure at the mid-urethral sphincter. A processing device is connected to the first and second pressure sensors and configured to receive the measured bladder pressure and measured mid-urethrai pressure during at least one breath cycle and process the data representative of the bladder and mid-urethral pressures obtained during the at least one breath cycle to diagnose a physiological abnormality within the patient.
A system evaluates a patient for a physiological abnormality. A urinary catheter is insertable within a patient's bladder and has a first pressure sensor for measuring bladder pressure and a second pressure sensor for measuring mid-urethral pressure at the mid-urethral sphincter. A processing device is connected to the first and second pressure sensors and configured to receive the measured bladder pressure and measured mid-urethral pressure during at least one breath cycle and process the data representative of the bladder and mid-urethral pressures obtained during the at least one breath cycle to diagnose a physiological abnormality within the patient.
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A nebulizer (900) includes a main body (901) that has a nebulizer outlet (902) and an air channel (910) in communication with the nebulizer outlet. The main body supports a medicine reservoir (920) and a mesh (922) that engages the medicine reservoir and air channel and vibrates to atomize medicine from the medicine reservoir into the air channel for discharge through the nebulizer outlet. The nebulizer outlet and mesh are configured to be received within the oral cavity of a patient when the nebulizer is in use. The nebulizer may comprise an air flow sensor (940) carried by the main body and configured to measure air flow generated by a patient's one of at least inhaling and exhaling air.
A nebulizer (700) includes a venturi nozzle positioned at the outlet (706) end of an air line and oriented horizontally and located within a patient's oral cavity when in use. A canister port is located at the inlet end of the air line and receives a gas canister (724). A valve is actuable to allow a metered flow of gas at a predetermined pressure and time to flow from the gas canister through the air line and venturi nozzle. A medication receiver (708) is carried by the nebulizer body proximal to the venturi nozzle. A suction line extends from the venturi nozzle to the medication receiver and draws medication upward from a medication container and mixes it with air passing through the venturi nozzle and nebulizes the medication.
An atomizer has a venturi nozzle (814) positioned at an outlet end (810b) of an air line (810) and has a discharge end and is oriented horizontally when in use and forms a mixing chamber (811) at its discharge end. A valve (825) is positioned at a canister port (822) and actuable to allow a metered flow of gas at a predetermined pressure and time through the air line and venturi nozzle. A suction line (836) extends from the venturi nozzle and mixing chamber to a medication receiver (808) and draws medication upward and mixes it with gas passing through the venturi nozzle into the mixing chamber and atomizes the medication into a mist.
A medication reservoir (58) is formed in the lower portion (152) of a nebulizer body (51) and covered to form an enclosed medication reservoir. A nozzle assembly is supported by a reservoir cover and includes an air line (66) having an inlet at one end and an outlet and a venturi nozzle (52) and venturi outlet. The air line, venturi nozzle and discharge outlet are horizontally oriented when in use and the venturi nozzle is located within a patient's oral cavity when the nebulizer is in use. Medication is drawn upward through a suction line (70) and mixed with air passing through the venturi nozzle and nebulized for discharge through the nebulizer outlet (60). The venturi nozzle and suction line are formed together and replaceable as one unit.
A medication reservoir is contained within a nebulizer body. An air line includes a distal end within the nebulizer body and venturi nozzle. A medication suction line extends from the medication reservoir to the venturi nozzle through which medication is drawn upward and mixed with air after passing through the venturi nozzle and nebulized for discharge through the nebulizer outlet. A valve is positioned within the air line proximal to the venturi nozzle and normally configured in a closed position until a negative inspiratory pressure is applied by a user to open the valve and allow air through the air line and venturi nozzle from a source of air and draw medication upward through the medication suction line for nebulization and discharge through the nebulizer outlet.
A nebulizer includes a nebulizer body (52) having an air channel section, medication reservoir and nebulizer outlet (60). An air line has an inlet at one end and extends through the air channel section and has a venturi nozzle (52) oriented horizontally when in use and an outlet and configured to form a low pressure mixing chamber (68). The air line (72) provides a pulsed flow of gas between the inlet and outlet end. The venturi nozzle and medication reservoir are received within an oral cavity of a patient when in use. A primary suction line (70) extends from the medication reservoir to the low pressure mixing chamber through which medication is drawn upward and mixed with gas passing through the venturi nozzle and nebulized for pulsed discharge through the nebulizer outlet during nebulization.
A device blocks emesis and/or reflex and includes a tube insertable into the esophagus. The tube includes an inflation lumen. A valve is carried by the tube and includes a flexible sheath having an upper edge secured onto the tube and a lower circumferential edge. An inflatable balloon is associated with the flexible sheath and in communication with the inflation lumen. Upon inflation of the balloon, the flexible sheath opens in a concave configuration towards the stomach and the unsecured lower circumferential edge engages the esophageal wall and blocks emesis and/or reflux from the stomach passing into the esophagus past the valve.
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61J 15/00 - Feeding-tubes for therapeutic purposes
A device to block emesis and/or reflux includes a tube insertable into the esophagus. A valve is carried by the tube and includes a flexible sheath having an upper edge secured onto the tube and an unsecured lower circumferential edge and configured such that upon contact with emesis and/or reflux from the stomach, the flexible sheath opens in a concave configuration towards the stomach and the unsecured lower circumferential edge engages the esophageal wall and blocks emesis and/or reflux from the stomach passing into the esophagus past the valve.
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A nasogastric/orogastric (Ng/Og) device includes a main lumen configured for at least one of gastric decompression, enteral feeding and enteral medication administration. An expandable esophageal cuff is carried by the device body and configured in a normally expanded position such that when inserted within the esophagus, the esophageal cuff conforms to the interior surface of the esophagus and emesis and/or reflux is blocked from passing out of the stomach and past the esophageal cuff. A vacuum lumen is carried by the device body and connected to the expandable esophageal cuff. When vacuum is applied, the esophageal cuff is contracted against the device body to permit the device to be inserted and placed within the esophagus. When the vacuum is released, the esophageal cuff expands against the interior surface of the esophagus.
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61J 15/00 - Feeding-tubes for therapeutic purposes
A61B 5/03 - Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 6/12 - Arrangements for detecting or locating foreign bodies
A61M 25/01 - Introducing, guiding, advancing, emplacing or holding catheters
A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems
A device (100) to block emesis and/or reflux includes a tube (101) insertable into the esophagus. A valve (108) is carried by the tube and includes a flexible sheath (109) having an upper edge (110) secured onto the tube and an unsecured lower circumferential edge (112) and configured such that upon contact with emesis and/or reflux from the stomach, the flexible sheath opens in a concave configuration towards the stomach and the unsecured lower circumferential edge engages the esophageal wall and blocks emesis and/or reflux from the stomach passing into the esophagus past the valve.
A device (300) blocks emesis and/or reflex and includes a tube (308) insertable into the esophagus. The tube includes an inflation lumen (304). A valve (306) is carried by the tube and includes a flexible sheath (310) having an upper edge (312) secured onto the tube and a lower circumferential edge (314). An inflatable balloon (320) is associated with the flexible sheath and in communication with the inflation lumen. Upon inflation of the balloon, the flexible sheath opens in a concave configuration towards the stomach and the unsecured lower circumferential edge engages the esophageal wall and blocks emesis and/or reflux from the stomach passing into the esophagus past the valve.
A nasogastric/orogastric (Ng/Og) device (100) includes a main lumen (502) configured for at least one of gastric decompression, enteral feeding and enteral medication administration. An expandable esophageal cuff (506) is carried by the device body and configured in a normally expanded position such that when inserted within the esophagus, the esophageal cuff conforms to the interior surface of the esophagus and emesis and/or reflux is blocked from passing out of the stomach and past the esophageal cuff. A vacuum lumen (504) is carried by the device body and connected to the expandable esophageal cuff. When vacuum is applied, the esophageal cuff is contracted against the device body to permit the device to be inserted and placed within the esophagus. When the vacuum is released, the esophageal cuff expands against the interior surface of the esophagus.
An atomizer has a venturi nozzle positioned at an outlet end of an air line and has a discharge end and is oriented horizontally when in use and forms a mixing chamber at its discharge end. A valve is positioned at a canister port and actuable to allow a metered flow of gas at a predetermined pressure and time through the air line and venturi nozzle. A suction line extends from the venturi nozzle and mixing chamber to a medication receiver and draws medication upward and mixes it with gas passing through the venturi nozzle into the mixing chamber and atomizes the medication into a mist.
A medication reservoir is formed in the lower portion of a nebulizer body and covered to form an enclosed medication reservoir. A nozzle assembly is supported by a reservoir cover and includes an air line having an inlet at one end and an outlet and a venturi nozzle and venturi outlet. The air line, venturi nozzle and discharge outlet are horizontally oriented when in use and the venturi nozzle is located within a patient's oral cavity when the nebulizer is in use. Medication is drawn upward through a suction line and mixed with air passing through the venturi nozzle and nebulized for discharge through the nebulizer outlet. The venturi nozzle and suction line are formed together and replaceable as one unit.
A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A system permits diagnosis of a patient for a physiological abnormality while protecting their airway. An esophageal airway protection device comprises an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. The device includes a main lumen extending the length of the device and an inflatable esophageal cuff carried by the device body mid-esophagus. Emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus when it is inflated to protect a patient's airway during an involuntary cough event. At least one electromyogram (EMG) pad is configured to obtain an EMG from an involuntary cough activated paraspinal muscles. A processing device is configured to receive the EMG and process the EMG to determine a physiological abnormality.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/04 - Measuring bioelectric signals of the body or parts thereof
An apparatus diagnoses at least one internal sphincter. A muscle contraction device is located on at least one of the urethral and anal sphincters. A controller is connected to the muscle contraction device and operative to transmit control signals to the muscle contraction device located on at least one of the urethral and anal sphincters to contract the muscle during an inspiratory phase of respiration.
A system and method tests the gastric valve and urethral sphincter in a patient. A contrast agent is administered into the esophagus of a patient followed by inducing an involuntary reflex cough epoch within the patient to isolate the gastric valve from the lower esophageal sphincter (LES) and isolate the external urethral sphincter from the internal urethral sphincter. An imaging sensor detects the flow of the contrast agent during the involuntary reflex cough epoch and determines whether stomach reflux occurred indicative of a malfunctioning gastric valve. A determination is made if urine leakage occurs indicative of stress urinary incontinence (SUI).
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A system and method tests the gastric valve in a patient. A contrast agent is supplied into the stomach of the patient. An involuntary reflex cough epoch is induced within the patient to isolate the gastric valve from the lower esophageal sphincter (LES). A fluoroscopic instrument is used to detect whether stomach reflux has occurred indicative of a malfunctioning gastric valve. The external urethral sphincter can also be tested to determine SUI.
A nebulizer includes a body, an air channel section and medication reservoir. An air line extends through the air channel section. A venturi nozzle is configured to form at its end a low pressure mixing chamber. A primary suction line extends from the medication reservoir to the low pressure mixing chamber through which medication is drawn upward into the low pressure mixing chamber and mixed with air from the venturi nozzle and nebulized for discharge through a nebulizer outlet. The venturi nozzle, low pressure mixing chamber and air channel section are configured such that at standard temperature and pressure (STP) a differential pressure results in no medication that is drawn upward through the primary suction line for nebulization and discharged the through the nebulizer outlet until a negative inspiratory pressure is created from inhalation by a user.
A nebulizer includes a body (51), an air channel section and medication reservoir (58). An air line (66) extends through the air channel section. A venturi nozzle (52) is configured to form at its end a low pressure mixing chamber (68). A primary suction line (70) extends from the medication reservoir to the low pressure mixing chamber through which medication is drawn upward into the low pressure mixing chamber and mixed with air from the venturi nozzle and nebulized for discharge through a nebulizer outlet. The venturi nozzle, low pressure mixing chamber and air channel section are configured such that at standard temperature and pressure (STP) a differential pressure results in no medication that is drawn upward through the primary suction line for nebulization and discharged the through the nebulizer outlet until a negative inspiratory pressure is created from inhalation by a user.
A nebulizer includes a body (50) having an air channel section, medication reservoir (58) and nebulizer outlet (60) configured to be received within an oral cavity of a patient. A nebulizer suction member encloses the body and is configured as an infant pacifier. An air line (66) extends through the air channel section and has a venturi nozzle (52) and at its end configured to form a low pressure mixing chamber. A primary suction line extends from the medication reservoir to the low pressure mixing chamber through which medication is drawn upward and mixed with air passing through the venturi nozzle and nebulized for discharge through the nebulizer outlet.
A system and method diagnoses acid reflux. A nasogatric/orogastric (Ng/Og) device is inserted through the esophagus and into the stomach of a patient. The Ng/Og device includes a pressure sensor configured to measure intra-abdominal pressure and a plurality of pH sensors positioned along the Ng/Og device. An involuntary reflex cough epoch is induced within the patient. The intra-abdominal pressure and elevation of reflux along the Ng/Og device is measured. A subsequent step determines the functional status of the gastric valve based on the measured intra-abdominal pressure and the elevational reflux along the catheter created by the increased intra-abdominal pressure that occurs during the involuntary reflex cough epoch.
A nasogastric/orogastric (Ng/Og) airway protection device includes an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. A main lumen extends the length of the device and is configured for at least one of gastric decompression, enteral feeding and enteral medication administration. A sump port is at the distal end. A sump lumen is formed the length of the device body and configured for venting gas and preventing adherence of the device against the gastric wall. An inflatable esophageal cuff is carried by the device body mid-esophagus and an inflation lumen is formed within the device body and connects the inflatable esophageal cuff through which the esophageal cuff is inflated and deflated. Upon inflation of the esophageal cuff, emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus to protect a patient's airway.
A system and method diagnoses esophageal reflux in a patient. A catheter (1500) includes a first pressure sensor (1510) configured to measure intra-abdominal pressure when the catheter is inserted into the stomach of a patient. A second pressure sensor (1512) is located proximal to the distal tip and configured to measure intra-thoracic pressure. A pH indicator (1520) is carried by the catheter body and configured to indicate that reflux has occurred in response to an involuntary reflex cough test. A processing device is configured to receive data regarding the first and second pressure sensors and regarding the pH indicator and process that data and assess if reflux is present during the involuntary epoch.
A system (1400) permits diagnosis of a patient for a physiological abnormality while protecting their airway. An esophageal airway protection device comprises an elongate device (1401) body having a distal end for insertion into the stomach through the esophagus and a proximal end. The device includes a main lumen extending the length of the device and an inflatable esophageal cuff carried by the device body mid-esophagus. Emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff (1402) positioned mid-esophagus when it is inflated to protect a patient's airway during an involuntary cough event. At least one electromyogram (EMG) pad is configured to obtain an EMG from an involuntary cough activated paraspinal muscles. A processing device is configured to receive the EMG and process the EMG to determine a physiological abnormality.
A nasogastric/orogastric (Ng/Og) airway protection device includes an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. A main lumen extends the length of the device and is configured for at least one of gastric decompression, enteral feeding and enteral medication administration. A sump port is at the distal end. A sump lumen is formed the length of the device body and configured for venting gas and preventing adherence of the device against the gastric wall. An inflatable esophageal cuff is carried by the device body mid-esophagus and an inflation lumen is formed within the device body and connects the inflatable esophageal cuff through which the esophageal cuff is inflated and deflated. Upon inflation of the esophageal cuff, emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus to protect a patient's airway.
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A system and method diagnoses esophageal reflux in a patient. A catheter includes a first pressure sensor configured to measure intra-abdominal pressure when the catheter is inserted into the stomach of a patient. A second pressure sensor is located proximal to the distal tip and configured to measure intra-thoracic pressure. A pH indicator is carried by the catheter body and configured to indicate that reflux has occurred in response to an involuntary reflex cough test. A processing device is configured to receive data regarding the first and second pressure sensors and regarding the pH indicator and process that data and assess if reflux is present during the involuntary epoch.
G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A system permits diagnosis of a patient for a physiological abnormality while protecting their airway. An esophageal airway protection device comprises an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. The device includes a main lumen extending the length of the device and an inflatable esophageal cuff carried by the device body mid-esophagus. Emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus when it is inflated to protect a patient's airway during an involuntary cough event. At least one electromyogram (EMG) pad is configured to obtain an EMG from an involuntary cough activated paraspinal muscles. A processing device is configured to receive the EMG and process the EMG to determine a physiological abnormality.
In accordance with non-limiting examples, a nebulizer includes a main body (200) comprising an air channel section (201) and further comprising a mixing chamber (330) and a venturi (310) positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor (280) is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
Techniques for detecting stress urinary incontinence use a pressure sensing catheter the electrical indications of which are applied to a processing unit for detecting pressure levels generated during involuntary coughs. The involuntary coughs are induced preferentially by using a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier. The area under the curve generated from pressure samples is calculated and used in conjunction with the detection of urine leakage to determine the existence of stress urinary incontinence.
An improved nebulizer places a venturi in close proximity to or inside a patient's oral cavity. One or more medicine feed lines feeds the medicine to a location proximate to a venturi. A plurality of medicines may be administered simultaneously to the patient, with preferably each medicine vial being shape-keyed to a medicine receiver of corresponding shape. The medicine vial or vials may contain a standard unit dose of medication. A portable gas canister can be utilized to supply air pressure to the venturi when a press open release closed type valve is actuated.
Techniques for detecting stress urinary incontinence use a pressure sensing catheter the electrical indications of which are applied to a processing unit for detecting pressure levels generated during involuntary coughs. The involuntary coughs are induced preferentially by using a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier. The area under the curve generated from pressure samples is calculated and used in conjunction with the detection of urine leakage to determine the existence of stress urinary incontinence.
Techniques for detecting stress urinary incontinence use a pressure sensing catheter the electrical indications of which are applied to a processing unit for detecting pressure levels generated during involuntary coughs. The involuntary coughs are induced preferentially by using a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier. The area under the curve generated from pressure samples is calculated and used in conjunction with the detection of urine leakage to determine the existence of stress urinary incontinence.
Techniques for detecting stress urinary incontinence use a pressure sensing catheter the electrical indications of which are applied to a processing unit for detecting pressure levels generated during involuntary coughs. The involuntary coughs are induced preferentially by using a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier. The area under the curve generated from pressure samples is calculated and used in conjunction with the detection of urine leakage to determine the existence of stress urinary incontinence.
An improved nebulizer places a venturi in a rainfall chamber and in close proximity to or inside a patient's oral cavity. One or more medicine feed lines feeds the medicine to a location proximate to a venturi. The rainfall chamber contains a sump communicating with the venturi for collecting medication not delivered to the patient and for recycling that medication for delivery to the patient. A medicine receiver may be pre-filled with a standard unit dose of medication.
A apparatus and method for self-treatment of cardiac arrhythmia by a patient, comprising a container sized to be portable by the patient and having therein a chamber containing a medicament composition comprising a pharmaceutically acceptable carrier mixed with a chemoirritant, preferably L-tartaric acid; a nebulizing valve connected to the chamber so as to provide an outlet therefor; a source of motivating force connected with the chamber so as to motivate the composition through the opening in the nebulizing valve to thereby cause nebulization of the composition; a wireless transmitter responsive to activation of the nebulizer for sending a wireless signal requesting medical assistance; and a power source operatively connected for providing power; wherein the chemoirritant is mixed in the composition in an amount sufficient for causing the patient to produce an involuntary cough effective to maintain at least partial blood circulation.